These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18716557)

  • 1. Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.
    Ilkovski B; Mokbel N; Lewis RA; Walker K; Nowak KJ; Domazetovska A; Laing NG; Fowler VM; North KN; Cooper ST
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):867-77. PubMed ID: 18716557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
    Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N
    Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy.
    Wattanasirichaigoon D; Swoboda KJ; Takada F; Tong HQ; Lip V; Iannaccone ST; Wallgren-Pettersson C; Laing NG; Beggs AH
    Neurology; 2002 Aug; 59(4):613-7. PubMed ID: 12196661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy.
    Tan P; Briner J; Boltshauser E; Davis MR; Wilton SD; North K; Wallgren-Pettersson C; Laing NG
    Neuromuscul Disord; 1999 Dec; 9(8):573-9. PubMed ID: 10619715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy.
    Ottenheijm CA; Lawlor MW; Stienen GJ; Granzier H; Beggs AH
    Hum Mol Genet; 2011 May; 20(10):2015-25. PubMed ID: 21357678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alphaTropomyosin mutation alters dimer preference in nemaline myopathy.
    Corbett MA; Akkari PA; Domazetovska A; Cooper ST; North KN; Laing NG; Gunning PW; Hardeman EC
    Ann Neurol; 2005 Jan; 57(1):42-9. PubMed ID: 15562513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disturbance of the contractile function of slow skeletal muscles induced by myopathic mutations in the tropomyosin TPM3 gene.
    Matyushenko AM; Nefedova VV; Shchepkin DV; Kopylova GV; Berg VY; Pivovarova AV; Kleymenov SY; Bershitsky SY; Levitsky DI
    FASEB J; 2020 Oct; 34(10):13507-13520. PubMed ID: 32797717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene.
    Malfatti E; Schaeffer U; Chapon F; Yang Y; Eymard B; Xu R; Laporte J; Romero NB
    Neuromuscul Disord; 2013 Dec; 23(12):992-7. PubMed ID: 24095155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy.
    Corbett MA; Robinson CS; Dunglison GF; Yang N; Joya JE; Stewart AW; Schnell C; Gunning PW; North KN; Hardeman EC
    Hum Mol Genet; 2001 Feb; 10(4):317-28. PubMed ID: 11157795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.
    Moraczewska J; Greenfield NJ; Liu Y; Hitchcock-DeGregori SE
    Biophys J; 2000 Dec; 79(6):3217-25. PubMed ID: 11106625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Compound Heterozygous Splice-Site Variants in TPM3 Revealed by RNA Sequencing in a Patient with an Unusual Form of Nemaline Myopathy: A Case Report.
    Pelin K; Sagath L; Lehtonen J; Kiiski K; Tynninen O; Paetau A; Johari M; Savarese M; Wallgren-Pettersson C; Lehtokari VL
    J Neuromuscul Dis; 2023; 10(5):977-984. PubMed ID: 37393515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.
    Lawlor MW; Dechene ET; Roumm E; Geggel AS; Moghadaszadeh B; Beggs AH
    Hum Mutat; 2010 Feb; 31(2):176-83. PubMed ID: 19953533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulin expression in patients with nemaline myopathy.
    Gurgel-Giannetti J; Reed U; Bang ML; Pelin K; Donner K; Marie SK; Carvalho M; Fireman MA; Zanoteli E; Oliveira AS; Zatz M; Wallgren-Pettersson C; Labeit S; Vainzof M
    Neuromuscul Disord; 2001 Mar; 11(2):154-62. PubMed ID: 11257471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course correlates poorly with muscle pathology in nemaline myopathy.
    Ryan MM; Ilkovski B; Strickland CD; Schnell C; Sanoudou D; Midgett C; Houston R; Muirhead D; Dennett X; Shield LK; De Girolami U; Iannaccone ST; Laing NG; North KN; Beggs AH
    Neurology; 2003 Feb; 60(4):665-73. PubMed ID: 12601110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation.
    Kiphuth IC; Krause S; Huttner HB; Dekomien G; Struffert T; Schröder R
    J Neurol; 2010 Apr; 257(4):658-60. PubMed ID: 20012312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
    Yuen M; Cooper ST; Marston SB; Nowak KJ; McNamara E; Mokbel N; Ilkovski B; Ravenscroft G; Rendu J; de Winter JM; Klinge L; Beggs AH; North KN; Ottenheijm CA; Clarke NF
    Hum Mol Genet; 2015 Nov; 24(22):6278-92. PubMed ID: 26307083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Variant in
    Robaszkiewicz K; Siatkowska M; Wadman RI; Kamsteeg EJ; Chen Z; Merve A; Parton M; Bugiardini E; de Bie C; Moraczewska J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy.
    Durling HJ; Reilich P; Müller-Höcker J; Mendel B; Pongratz D; Wallgren-Pettersson C; Gunning P; Lochmüller H; Laing NG
    Neuromuscul Disord; 2002 Dec; 12(10):947-51. PubMed ID: 12467750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene.
    Ilkovski B; Cooper ST; Nowak K; Ryan MM; Yang N; Schnell C; Durling HJ; Roddick LG; Wilkinson I; Kornberg AJ; Collins KJ; Wallace G; Gunning P; Hardeman EC; Laing NG; North KN
    Am J Hum Genet; 2001 Jun; 68(6):1333-43. PubMed ID: 11333380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rod distribution and muscle fiber type modification in the progression of nemaline myopathy.
    Gurgel-Giannetti J; Reed UC; Marie SK; Zanoteli E; Fireman MA; Oliveira AS; Werneck LC; Beggs AH; Zatz M; Vainzof M
    J Child Neurol; 2003 Mar; 18(3):235-40. PubMed ID: 12731651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.